Norbert Graf

Norbert Graf is an expert in Oncology at Universitätsklinikum des Saarlandes (Germany). As of October 2026, ScienceLeadR ranks Norbert Graf in the top 1% of experts worldwide for Kidney Neoplasms, Urologic Neoplasms and Urogenital Neoplasms. Norbert Graf has authored 538 publications, the most recent in 2026, and is an investigator in 12 clinical trials, 2 of them ongoing. SLR score: 1,509 (community average: 125). How the SLR is computed.

Oncology

Subspecialties: Hematology - Pediatrics - Neurology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on October 26, 2026

Expert Rankings

Top experts on the MeSH terms this expert works on

Top Urogenital Neoplasms key opinion leaders

Organizations

Career arc: 1980 - 2026

Source: PubMed

Universitätsklinikum des Saarlandes

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 538

Citations

Citations: 19 882 1st author: 21 Last author: 104 Unique author: 4

Main journals

Pediatr Blood Cancer 45

Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title	Journal	Year	Citations
A comprehensive review of European clinical practice guidelines on psychological and cognitive assessment and support for cancer patients and their families. PMID 42873364 — neoplasms, palliative care	Support Care Cancer	2026	0
Digital solutions for tackling mental health in cancer patients and their families: The ALTHEA project. PMID 42842547 — neoplasms, solutions, therapeutics, mental health	PLOS Digit Health	2026	0
Blinatumomab for Replacing Chemotherapy in Pediatric Acute Lymphoblastic Leukemia. PMID 42748428 — cells, precursor cell lymphoblastic leukemia-lymphoma, disease-free survival, leukemia, drug therapy, therapeutics, random allocation, b-lymphocytes, child, chemotherapy	N Engl J Med Top journal	2026	2
Feasibility of Implementing an Electronic Patient-Reported Outcome-Based Digital Health Platform in Pediatric Oncology and Palliative Care: Insights From the MyPal4Kids Multicenter Observational Study. PMID 42579605 — communication, workflow, palliative care, child, digital health	JMIR Cancer	2026	0
Nephrogenic Rests/Nephroblastomatosis in Patients With Unilateral Wilms Tumor Are Not Associated With an Increased Risk of Relapse: An Analysis of Patients Treated on the SIOP-WT-2001 Protocol in the SIOP-UK-CCLG and SIOP-GPOH Studies (2001-2022). PMID 42535789 — regression analysis, neoplasms, wilms tumor, histology	Pediatr Blood Cancer	2026	0

Clinical Studies 12

Sources: ClinicalTrials, EU CTIS

Synthesis

Study Chair: 1 Study Director: 1

By phase:

N/A 5

Phase 3 5

Phase 2 1

Phase 2/Phase 3 1

By status:

Unknown 7

Completed 2

Recruiting 2

Not yet recruiting 1

By type:

Interventional 11

Observational 1

By Monocentric/Multicentric:

monocentric 4

multicentric2to4 3

multicentric5to9 1

multicentricup10 4

Main Topics

Hemic and Lymphatic Diseases 2

Immune System Diseases 2

Cohort/Consortium Investigators 1

Ongoing Clinical Trials

2 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study	Phase	Status	Start
Digital Solutions for bEtter cAre NCT07416513 — focus groups, caregivers, neoplasms, solutions, health personnel, diagnosis, mental health	N/A	Recruiting	2025
AlloLife Life After Transplantation NCT05087784 — cells, microscopy, electron, scanning transmission, hematopoietic stem cell transplantation, stem cells, physicians, wearable electronic devices, survivorship, transplants, cell transplantation, stem cell transplantation, hematopoietic stem cells, transplantation, cardio-oncology	N/A	Not yet recruiting	2024

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS

Shopping Cart

System Maintenance Notice